All In Biotech

Drug Trial Radar · NCT00528112

Levonorgestrel Contraceptive Intrauterine Systems (LCS) Pearl Index Study

Multi-Center, Open-Label, Randomized Study to Assess the Safety and Contraceptive Efficacy of Two Doses ( in vitro12 µg/24h and 16 µg/24h) of the Ultra Low Dose Levonorgestrel Contraceptive Intrauterine Systems (LCS) for a Maximum of 3 Years in Women 18 to 35 Years of Age and an Extension Phase of the 16µg/24h Dose Group (LCS16 Arm) up to 5 Years

Last checked: Nov 19, 2026Latest source record: Jan 25, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 2,885 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,885

Actual

Start

Aug 2007

Primary completion

Jul 2011

Study completion Jun 2013

Sponsor

Lead sponsor
BayerBayer (BAYRY)
Sponsor type
Industry
First posted
Sep 12, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
Female only, from 18 years, up to 35 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a study on a new low dose levonorgestrel contraceptive intrauterine systems (LCS). The purpose of the study is to investigate which of the 2 administered doses is the lowest effective intrauterine dose of Levonorgestrel (LNG) administered via the LCS for contraception during 3 years. The study was amended: the LCS16 arm will be extended up to 5 years

Conditions

  • Contraception

Interventions

  • LCS12Drug

    Intrauterine system (IUS) with Levonorgestrel, in vitro releasing rate 12 microg/24 h

  • LCS16Drug

    Intrauterine system (IUS) with Levonorgestrel, in vitro releasing rate 16 microg/24 h

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pearl Index up to 3 YearsTime frame: Up to 3 years
  2. Pearl Index for LCS16 up to 5 YearsTime frame: Up to 5 years

Locations

136 sites in 11 countries. Site status is shown where the registry gives one.

  • Site not named

    Mobile, Alabama

  • Site not named

    Glendale, Arizona

  • Site not named

    Phoenix, Arizona

  • Site not named

    Tucson, Arizona

  • Site not named

    Carmichael, California

  • Site not named

    Pacific Palisades, California

  • Site not named

    San Diego, California

  • Site not named

    San Diego, California

  • Site not named

    San Diego, California

  • Site not named

    San Diego, California

  • Site not named

    Torrance, California

  • Site not named

    Denver, Colorado

  • Site not named

    Littleton, Colorado

  • Site not named

    Boyton Beach, Florida

  • Site not named

    Jacksonville, Florida

  • Site not named

    Miami, Florida

  • Site not named

    West Palm Beach, Florida

  • Site not named

    Atlanta, Georgia

  • Site not named

    Decatur, Georgia

  • Site not named

    Boise, Idaho

  • Site not named

    Idaho Falls, Idaho

  • Site not named

    Chicago, Illinois

  • Site not named

    Evansville, Indiana

  • Site not named

    South Bend, Indiana

  • Site not named

    Marrero, Louisiana

  • Site not named

    Boston, Massachusetts

  • Site not named

    Kalamazoo, Michigan

  • Site not named

    Chaska, Minnesota

  • Site not named

    Chesterfield, Missouri

  • Site not named

    Lincoln, Nebraska

  • Site not named

    Las Vegas, Nevada

  • Site not named

    Las Vegas, Nevada

  • Site not named

    Las Vegas, Nevada

  • Site not named

    Moorestown, New Jersey

  • Site not named

    New Brunswick, New Jersey

  • Site not named

    Albuquerque, New Mexico

  • Site not named

    New York, New York

  • Site not named

    New Bern, North Carolina

  • Site not named

    Winston-Salem, North Carolina

  • Site not named

    Cincinnati, Ohio

Showing 40 of 136 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.